ArticlePharmaceutics2026

A Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin in Type 2 Diabetes Mellitus: The Effect of Dosing, Hepatorenal Impairment, and Food.

Nike Nemitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.